Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSophos Group Regulatory News (SOPH)

  • There is currently no data for SOPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RESULT OF PLACING IN SOPHOS GROUP PLC

28 Nov 2017 07:00

RNS Number : 6596X
UBS Limited
28 November 2017
 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

PLACING OF 51.2 MILLION ORDINARY

SHARES IN SOPHOS GROUP PLC ("COMPANY")

 

28 November 2017

 

Pentagon Lock S.à r.l., Pentagon Lock 6-A S.à r.l., Pentagon Lock 7-A S.à r.l., Pentagon Lock US S.à r.l. and Apax Global Alpha Limited (the "Sellers") have sold an aggregate of 51,186,432 ordinary shares in the capital of the Company at a price of 616 pence per share (the "Placing") raising aggregate gross sale proceeds of £315.3 million through the Placing.

 

Following completion of the Placing, the Sellers will hold (in aggregate) approximately 11.2 per cent of the Company's issued ordinary shares.

 

The proceeds of the Placing are payable in cash on usual settlement terms, and closing of the Placing is expected to occur on 30 November 2017, subject to the satisfaction or waiver of certain customary conditions.

 

UBS Limited is acting as Sole Bookrunner (the "Bookrunner") in connection with the Placing. Moelis & Company UK LLP is acting as financial advisor to the Sellers.

 

The Company will not receive any proceeds from the Placing.

 

The ordinary shares in the capital of the Company retained by the Sellers following the Placing will be subject to a lock-up until the date which is 90 days after the date of this announcement, subject to customary exceptions and waiver by the Bookrunner.

 

 

Important Notice

 

MEMBERS OF THE GENERAL PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING. THIS ANNOUNCEMENT AND ANY OFFER OF SECURITIES TO WHICH IT RELATES ARE ONLY ADDRESSED TO AND DIRECTED AT (1) IN ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA, PERSONS WHO ARE QUALIFIED INVESTORS WITHIN THE MEANING OF ARTICLE 2(1)(E) OF EU DIRECTIVE 2003/71/EC (AS AMENDED BY DIRECTIVE 2010/73/EU TO THE EXTENT IMPLEMENTED IN THE RELEVANT MEMBER STATE) AND ANY RELEVANT IMPLEMENTING MEASURES (THE "PROSPECTUS DIRECTIVE"); AND (2) IN THE UNITED KINGDOM, PERSONS WHO (I) HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS WHO FALL WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005 (AS AMENDED) (THE "ORDER"); OR (II) FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER OR (III) ARE PERSONS TO WHOM AN OFFER OF THE PLACING SHARES MAY OTHERWISE LAWFULLY BE MADE (ALL SUCH PERSONS REFERRED TO IN (1) AND (2) TOGETHER BEING REFERRED TO AS "RELEVANT PERSONS"). THE INFORMATION REGARDING THE PLACING SET OUT IN THIS ANNOUNCEMENT MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS.

 

THIS ANNOUNCEMENT DOES NOT, AND SHALL NOT, IN ANY CIRCUMSTANCES CONSTITUTE A PUBLIC OFFERING, NOR AN OFFER TO SELL OR TO SUBSCRIBE FOR, NOR A SOLICITATION TO OFFER TO PURCHASE OR TO SUBSCRIBE FOR SECURITIES IN ANY JURISDICTION. THE DISTRIBUTION OF THIS ANNOUNCEMENT AND THE OFFERING OR SALE OF THE PLACING SHARES IN CERTAIN JURISDICTIONS MAY BE RESTRICTED BY LAW. NO ACTION HAS BEEN TAKEN BY THE SELLERS (OR ANY AFFILIATES THEREOF), APAX PARTNERS LLP ("APAX PARTNERS"), ANY FUNDS ADVISED BY APAX PARTNERS (OR THE GENERAL PARTNER THEREOF) (TOGETHER, THE "APAX FUNDS") OR ANY OF THE BOOKRUNNER OR ANY OF ITS AFFILIATES THAT WOULD, OR WHICH IS INTENDED TO, PERMIT A PUBLIC OFFER OF THE PLACING SHARES IN ANY JURISDICTION OR POSSESSION OR DISTRIBUTION OF THIS ANNOUNCEMENT OR ANY OTHER OFFERING OR PUBLICITY MATERIAL RELATING TO THE PLACING SHARES IN ANY JURISDICTION WHERE ACTION FOR THAT PURPOSE IS REQUIRED. PERSONS INTO WHOSE POSSESSION THIS ANNOUNCEMENT COMES ARE REQUIRED BY THE SELLERS, APAX PARTNERS, THE APAX FUNDS AND ANY OF THE BOOKRUNNER TO INFORM THEMSELVES ABOUT AND TO OBSERVE ANY APPLICABLE RESTRICTIONS.

 

WITH RESPECT TO THE MEMBER STATES OF THE EUROPEAN ECONOMIC AREA WHICH HAVE IMPLEMENTED THE PROSPECTUS DIRECTIVE (EACH, A "RELEVANT MEMBER STATE"), NO ACTION HAS BEEN UNDERTAKEN OR WILL BE UNDERTAKEN TO MAKE AN OFFER TO THE PUBLIC OF THE PLACING SHARES SOLD BY THE SELLERS REQUIRING A PUBLICATION OF A PROSPECTUS IN ANY RELEVANT MEMBER STATE. AS A CONSEQUENCE, THE PLACING SHARES MAY ONLY BE OFFERED OR SOLD IN ANY RELEVANT MEMBER STATE PURSUANT TO AN EXEMPTION UNDER THE PROSPECTUS DIRECTIVE.

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OF, OR THE SOLICITATION OF AN OFFER TO ACQUIRE OR DISPOSE OF SECURITIES IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR IN ANY OTHER JURISDICTION IN WHICH SUCH AN OFFER OR SOLICITATION IS UNLAWFUL.

 

THE PLACING SHARES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE "US SECURITIES ACT"), OR UNDER THE APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION OF THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN. THE PLACING SHARES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES UNLESS REGISTERED UNDER THE US SECURITIES ACT OR OFFERED IN A TRANSACTION EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT AND THE SECURITIES LAWS OF ANY RELEVANT STATE OR OTHER JURISDICTION OF THE UNITED STATES. THERE WILL BE NO PUBLIC OFFERING OF THE PLACING SHARES IN THE UNITED STATES OR ELSEWHERE.

 

THE PLACING SHARES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE US SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY IN THE UNITED STATES, NOR HAVE ANY OF THE FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE MERITS OF THE PLACING OR THE ACCURACY OR ADEQUACY OF THIS ANNOUNCEMENT. ANY REPRESENTATION TO THE CONTRARY IS A

CRIMINAL OFFENCE IN THE UNITED STATES.

 

NO PROSPECTUS OR OFFERING DOCUMENT HAS BEEN OR WILL BE PREPARED IN CONNECTION WITH THE PLACING. ANY INVESTMENT DECISION TO BUY SECURITIES IN THE PLACING MUST BE MADE SOLELY ON THE BASIS OF PUBLICLY AVAILABLE INFORMATION. SUCH INFORMATION IS NOT THE RESPONSIBILITY OF AND HAS NOT BEEN INDEPENDENTLY VERIFIED BY THE SELLERS (OR AN AFFILIATE THEREOF), APAX PARTNERS, ANY APAX FUND OR ANY OF THE BOOKRUNNER OR ANY OF ITS RESPECTIVE AFFILIATES. THE BOOKRUNNER IS AUTHORISED BY THE PRUDENTIAL REGULATION AUTHORITY ("PRA") AND REGULATED IN THE UNITED KINGDOM BY THE PRA AND FINANCIAL CONDUCT AUTHORITY ("FCA"). MOELIS & COMPANY UK LLP IS AUTHORISED AND REGULATED BY THE FCA. THE BOOKRUNNER AND MOELIS & COMPANY UK LLP ARE ACTING EXCLUSIVELY FOR THE SELLERS IN CONNECTION WITH THE PLACING AND WILL NOT BE RESPONSIBLE TO ANYONE OTHER THAN THE SELLER FOR PROVIDING THE PROTECTIONS OFFERED TO ITS CLIENTS, NOR FOR PROVIDING ADVICE IN RELATION TO THE PLACING OR ANY TRANSACTION, MATTER OR ARRANGEMENT REFERRED TO IN THIS ANNOUNCEMENT.

 

IN CONNECTION WITH THE OFFERING OF THE PLACING SHARES, THE BOOKRUNNER OR ANY OF ITS RESPECTIVE AFFILIATES MAY TAKE UP A PORTION OF THE PLACING SHARES AS A PRINCIPAL POSITION AND IN THAT CAPACITY MAY RETAIN, PURCHASE OR SELL FOR ITS OWN ACCOUNTS SUCH SECURITIES. IN ADDITION THEY MAY ENTER INTO FINANCING ARRANGEMENTS AND SWAPS WITH INVESTORS IN CONNECTION WITH WHICH THEY MAY FROM TIME TO TIME ACQUIRE, HOLD OR DISPOSE OF THE PLACING SHARES. THEY DO NOT INTEND TO DISCLOSE THE EXTENT OF ANY SUCH INVESTMENT OR TRANSACTIONS OTHERWISE THAN IN ACCORDANCE WITH ANY LEGAL OR REGULATORY OBLIGATION TO DO SO.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGGAWGUPMPPM
Date   Source Headline
2nd Mar 20203:20 pmRNSForm 8.3 - Sophos Group PLC
2nd Mar 20203:15 pmBUSFORM 8.3 - SOPHOS GROUP PLC
2nd Mar 202012:52 pmBUSFORM 8.3 - SOPHOS GROUP PLC
2nd Mar 202012:50 pmRNSForm 8.3 - Sophos Group plc
2nd Mar 202011:07 amRNSForm 8.5 (EPT/RI)
2nd Mar 202010:52 amRNSForm 8.5 (EPT/RI)Sophos Group plc
2nd Mar 202010:38 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
2nd Mar 20209:10 amRNSScheme of arrangement
2nd Mar 20207:30 amRNSSuspension-Sophos Group PLC
28th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
28th Feb 20203:15 pmBUSForm 8.3 - Sophos Group PLC
28th Feb 20203:03 pmBUSForm 8.3 - Sophos Group plc
28th Feb 20202:44 pmRNSForm 8.3 - Sophos Group Plc
28th Feb 20201:53 pmRNSHolding(s) in Company
28th Feb 20201:28 pmRNSForm 8.3 - Sophos Group Plc
28th Feb 202011:37 amRNSForm 8.5 (EPT/RI)
28th Feb 202011:06 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
28th Feb 202010:27 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
27th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
27th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
27th Feb 20202:38 pmBUSFORM 8.3 - SOPHOS GROUP PLC
27th Feb 20202:24 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc
27th Feb 20202:22 pmBUSForm 8.3 - Sophos Group PLC
27th Feb 20202:04 pmRNSForm 8.3 - Sophos Group PLC
27th Feb 20201:07 pmRNSScheme Timetable Update
27th Feb 202011:55 amRNSForm 8.3 - Sophos Group Plc
27th Feb 202011:28 amRNSForm 8.5 (EPT/RI)
27th Feb 202011:23 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
27th Feb 202010:43 amRNSForm 8.5 (EPT/NON-RI)- Sophos Group plc
27th Feb 202010:40 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
27th Feb 20208:23 amRNSRule 2.9 Announcement
26th Feb 20206:15 pmRNSSophos Group
26th Feb 20204:41 pmRNSScheme Timetable Update
26th Feb 20204:29 pmRNSForm 8.3 - Sophos Group Plc
26th Feb 20203:30 pmRNSForm 8.3 - SOPH LN
26th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
26th Feb 20203:19 pmRNSForm 8.3 - Sophos Group PLC
26th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
26th Feb 20202:57 pmRNSForm 8 (DD) - Sophos Group Plc
26th Feb 20202:51 pmRNSDirector/PDMR Shareholding
26th Feb 20201:31 pmBUSFORM 8.3 - SOPHOS GROUP PLC
26th Feb 202011:26 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
26th Feb 202010:56 amRNSForm 8.5 (EPT/RI)
26th Feb 202010:34 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
25th Feb 20204:39 pmRNSForm 8.3 - Sophos Group plc
25th Feb 20203:43 pmRNSForm 8.5 (EPT/RI) - Amendment
25th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
25th Feb 20203:15 pmBUSFORM 8.3 - SOPHOS GROUP PLC
25th Feb 20203:00 pmBUSForm 8.3 - SOPHOS GROUP PLC
25th Feb 20202:29 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.